These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7005)

  • 1. Subsynaptosomal distribution, inhibition, and characterization of the binding of (14C) 5-OH-indole-3-acetaldehyde to brain preparations.
    Ungar F; Alivisatos SG
    Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):449-64. PubMed ID: 7005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsynaptosomal localization and biochemical characterization of serotonin binding sites in the brain.
    Ungar F; Callaghan OH; Arora RC; Alivisatos SG
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):409-24. PubMed ID: 186852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of monoamine oxidase inhibitors on the borohydride stabilizable binding of serotonin and tryptamine in brain.
    Ungar F; Callaghan OH
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):191-9. PubMed ID: 877408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some biochemical properties of the new potential antidepressant agent N-methyl-N-propargyl-2-(1-methyl-5-methoxyindolyl)methylamine.
    Carranza Gómez-Carpintero M; Ochoa Estomba MC
    Arzneimittelforschung; 1993 Sep; 43(9):937-41. PubMed ID: 8240453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and ultrastructural maturation of serotonergic synapses during ontogeny.
    Tissari AH
    Med Biol; 1975 Feb; 53(1):1-14. PubMed ID: 1095838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent studies with 4-chloramphetamine and some analogues.
    Fuller RW; Molloy BB
    Adv Biochem Psychopharmacol; 1974; 10():195-205. PubMed ID: 4846538
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on membrane receptor sites for serotonin in the brain.
    Ungar F; Callaghan OH
    Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):205-24. PubMed ID: 15304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y; Mash D; Zhang SH; Stein I
    Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
    Yáñez M; Fraiz N; Cano E; Orallo F
    Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE; Nichols DE
    J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that 5-methoxy-N, N-dimethyl tryptamine is a specific substrate for MAO-A in the rat: implications for the indoleamine dependent behavioural syndrome.
    Squires RF
    J Neurochem; 1975 Jan; 24(1):47-50. PubMed ID: 1053788
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of chlorpromazine, imipramine and lithium on MAO-A and MAO-B activity in rat brain mitochondria.
    Nag M
    Indian J Exp Biol; 2004 Sep; 42(9):941-4. PubMed ID: 15462192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of prolonged cold exposure on monoamine oxidase activity and kinetics and on serotonin metabolism in the rat brain].
    Molodtsova GF
    Biull Eksp Biol Med; 1983 Sep; 96(9):16-8. PubMed ID: 6193823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone inhibition of 3H-5-hydroxytryptamine uptake by synaptosomes.
    Ciofalo FR
    J Pharmacol Exp Ther; 1974 Apr; 189(1):83-9. PubMed ID: 4823302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.